Cargando…
Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities
Acute lymphoblastic leukemia (ALL) is the most common cancer in children and one of the success stories in cancer therapeutics. Risk-directed therapy based on clinical, biologic and genetic features has played a significant role in this accomplishment. Despite the observed improvement in survival ra...
Autores principales: | Kourti, Maria, Aivaliotis, Michalis, Hatzipantelis, Emmanouel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487225/ https://www.ncbi.nlm.nih.gov/pubmed/37685286 http://dx.doi.org/10.3390/diagnostics13172748 |
Ejemplares similares
-
Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities
por: López Villar, Elena, et al.
Publicado: (2014) -
The Microbiome in Childhood Acute Lymphoblastic Leukemia
por: Oldenburg, Marina, et al.
Publicado: (2021) -
Rare non-Wilms' tumors in children
por: Kourti, Maria, et al.
Publicado: (2012) -
Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions
por: Thastrup, Maria, et al.
Publicado: (2022) -
Obesity in patients with acute lymphoblastic leukemia in childhood
por: Iughetti, Lorenzo, et al.
Publicado: (2012)